Normal Sleep Physiology
• Sleep architecture:
o Cycles of non-REM (N1, N2, N3) and REM sleep.
o REM sleep first occurs ~90 minutes after sleep onset.
o Non-REM = restorative, slow-wave (N3 most deep).
• Age effects:
o ↓ Slow-wave sleep with age.
o ↑ Nocturnal awakenings.
• REM sleep in mood disorders:
o Reduced REM latency (enters REM earlier) in depression.
o Increased REM density.
Insomnia
• Definition: Difficulty initiating or maintaining sleep, early waking, non-restorative sleep.
• Classification:
o Short-term: <3 months; usually stress-related.
o Chronic: >3 months, ≥3 nights/week.
• Management:
o First-line: CBT for insomnia (CBT-i).
o Sleep hygiene: regular schedule, avoid caffeine/alcohol, reduce screen time.
o Avoid long-term benzodiazepines or Z-drugs (risk of dependence).
• Medications (only if severe, short-term use):
o Short-acting hypnotics (e.g., zopiclone).
o Melatonin in elderly (limited role).
Narcolepsy
• Features:
o Excessive daytime sleepiness ("sleep attacks").
o Cataplexy: sudden muscle weakness triggered by emotions (laughter, anger).
o Hypnagogic (on falling asleep) or hypnopompic (on waking) hallucinations.
o Sleep paralysis.
• Diagnosis:
o Multiple Sleep Latency Test (MSLT): mean sleep latency <8 min + ≥2 sleep-onset REM periods.
o CSF hypocretin (orexin) levels low in some cases.
• Treatment:
o Modafinil first-line for daytime sleepiness.
o Sodium oxybate or antidepressants may help cataplexy.
• Associations:
o Strong HLA-DQB1*0602 association.
Sleep Apnoea
• Obstructive Sleep Apnoea (OSA):
o Repeated upper airway obstruction → hypoxia, arousals.
o Risk factors: obesity, male, craniofacial abnormalities, alcohol/sedatives.
• Clinical features:
o Loud snoring.
o Witnessed apnoeas.
o Excessive daytime sleepiness (Epworth Sleepiness Scale often used).
• Diagnosis:
o Polysomnography (gold standard).
o Apnoea–hypopnoea index (AHI):
Mild: 5–15/hr.
Moderate: 15–30/hr.
Severe: >30/hr.
• Treatment:
o CPAP (continuous positive airway pressure).
o Weight loss, avoid alcohol/sedatives, positional therapy.
• Complications:
o Hypertension, arrhythmias, pulmonary hypertension, insulin resistance.
Parasomnias
• NREM-related (arousal disorders):
o Sleepwalking (somnambulism).
o Sleep terrors: sudden arousals, screaming, autonomic signs.
o Common in children; amnesia for event.
• REM-related:
o REM sleep behaviour disorder (RBD):
Dream enactment, violent movements.
Strongly associated with synucleinopathies: Parkinson’s, Lewy body dementia, MSA.
o Nightmares: vivid, recalled upon waking.
• Treatment:
o Reassurance, safety precautions (e.g., safe environment).
o Clonazepam sometimes used in severe RBD.
Extra Revision Pearls
• RBD can precede Parkinsonism by years → important prodromal clue.
• OSA → secondary polycythaemia due to nocturnal hypoxia.
• In narcolepsy, cataplexy is pathognomonic but not always present.
• Hypnagogic hallucinations = “going to sleep”, hypnopompic = “popping out” of sleep.
• Insomnia is often secondary to mood disorders → always screen for depression/anxiety.